Article
ADAM12: a novel first‐trimester maternal serum marker for Down syndrome
10 Dec 2003
Abstract excerpt
OBJECTIVES: The concentration of bioavailable insulin-like growth factor (IGF) I and II is important to foetal growth. It is regulated by insulin-like growth factor binding proteins (IGFBP) 1 through 6. Proteolytic cleavage of IGFBP-3 takes place in human pregnancy serum; accordingly, IGFBP-3 serum levels decrease markedly during pregnancy. ADAM12 (A disintegrin and metalloprotease) is an IGFBP-3 and IGFBP-5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
